The Harrington Cancer and Health Foundation is offering free prostate cancer screenings for men ages 45 to 75 on Thursday, Oct. 15, at Pondaseta Brewing in Amarillo.
The event runs from 5:30 p.m. Until 8 p.m. At the brewery, which sits at 7500 S.W. 45th Ave. Organizers say it is open to men across the Panhandle region. The screening uses a prostate-specific antigen blood test, called a PSA test.
Every man screened enters a drawing to win $1,000. Participants can also pick up a ticket for one free pint, good the same evening.
Ryan Parnell, director of the Cancer Survivorship Center, put the goal plainly.
"Prostate cancer can often develop without obvious symptoms, which makes conversations about risk and screening especially important," Parnell said. "We want to remove barriers and give local men an easy opportunity to take a proactive step for their health. It's a simple blood test, it's free, and this year there are literally 1,000 reasons to get screened."
According to the American Cancer Society, about one in eight men will be diagnosed with prostate cancer during their lifetime.
Common questions
Where and when is the free prostate cancer screening in Amarillo?
- The free screening is Thursday, Oct. 15, from 5:30 p.m. until 8 p.m. at Pondaseta Brewing, 7500 S.W. 45th Ave. in Amarillo. The Harrington Cancer and Health Foundation is hosting it. Organizers say it is open to men across the Panhandle region.
Who can get screened, and what does the test involve?
- Men ages 45 to 75 can get screened. The test is a prostate-specific antigen blood test, called a PSA test. Every man screened enters a drawing to win $1,000, and participants can also pick up a ticket for one free pint, good the same evening.
Why does prostate cancer screening matter?
- Prostate cancer can often develop without obvious symptoms, according to Ryan Parnell, director of the Cancer Survivorship Center. He says that makes conversations about risk and screening especially important. The event aims to remove barriers for men who want to be screened.